Company Profile
AstraZeneca Pharma India Limited, a biopharmaceutical company manufactures, markets, and trades in pharmaceutical products in India and globally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions.
Its portfolio also includes oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names, rare diseases medicines under the Koselugo brand name, and respiratory medicines under the Symbicort and Fasenra brand names
Medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.